GUMDROP : Phase II Study of Bipolar Androgen-based Therapy for Men with Androgen Ablation Naive Recurrent Prostate Cancer 

Created by Nancy Dawson, last modified on Apr 28, 2013
Description:The purpose of this study is to determine the safety and clinical effects of alternating androgen deprivation therapy with testosterone therapy in men with recurrent prostate cancer as first line hormonal therapy, to assess the effect of alternating therapy on quality of life and metabolic changes associated with androgen-deprivation therapy.
Link:http://clinicaltrials.gov/ct2/show/NCT01750398
Site:Johns Hopkins University
Principal Investigator:Samuel Denmeade, MD